1. Home
  2. ANIX vs RVSB Comparison

ANIX vs RVSB Comparison

Compare ANIX & RVSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

N/A

Current Price

$2.60

Market Cap

103.9M

Sector

Health Care

ML Signal

N/A

Logo Riverview Bancorp Inc

RVSB

Riverview Bancorp Inc

N/A

Current Price

$6.50

Market Cap

120.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ANIX
RVSB
Founded
1982
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
103.9M
120.5M
IPO Year
2013
1997

Fundamental Metrics

Financial Performance
Metric
ANIX
RVSB
Price
$2.60
$6.50
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $9.67
N/A
AVG Volume (30 Days)
★ 182.3K
46.6K
Earning Date
09-09-2026
10-27-2026
Dividend Yield
N/A
★ 1.25%
EPS Growth
★ 12.82
N/A
EPS
N/A
★ 0.18
Revenue
★ $210,000.00
N/A
Revenue This Year
N/A
$42.74
Revenue Next Year
N/A
$5.53
P/E Ratio
★ N/A
$36.04
Revenue Growth
N/A
N/A
52 Week Low
$2.32
$4.88
52 Week High
$5.46
$6.72

Technical Indicators

Market Signals
Indicator
ANIX
RVSB
Relative Strength Index (RSI) 39.95 64.38
Support Level $2.48 $5.23
Resistance Level $3.09 N/A
Average True Range (ATR) 0.21 0.17
MACD -0.06 0.02
Stochastic Oscillator 6.71 68.18

Price Performance

Historical Comparison
ANIX
RVSB

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

About RVSB Riverview Bancorp Inc

Riverview Bancorp Inc is the bank holding company. The Company's operations are managed along two operating segments, consisting of banking operations performed by the Bank and trust and investment services performed by the Trust Company. The Bank is engaged mainly in the business of attracting deposits from the general public and using such funds, together with other borrowings, to make various commercial business, commercial real estate, land, multi-family real estate, real estate construction and consumer loans. Additionally, the Trust Company offers trust and investment. Its operations into two operating segments, consisting of banking operations and trust and investment services, these operating segments are aggregated into a single reportable operating segment.

Share on Social Networks: